Avneet Soin, MD.

Research Update

Cognitive Training Extends Ketamine’s Benefits

February 1, 2024

Avneet Soin, MD.

Avneet Soin, MD. Dr. Soin has no financial relationships with companies related to this material.

A positive psychology program hopes to boost the short-lived benefits of ketamine infusion.

Do Personality Traits Impact Antidepressant Efficacy?

October 3, 2023

Avneet Soin, MD.

Avneet Soin, MD. Dr. Soin has no financial relationships with companies related to this material.

Neuroticism is one of the most common traits in psychiatric practice, and it may inform response to mirtazapine vs. SSRIs.

The Antipsychotic-Stimulant Combo

September 1, 2023

Avneet Soin, MD., Chris Aiken, MD, and Deepti Anbarasan, MD.

Avneet Soin, MD. Psychiatry resident, NYU Grossman School of Medicine. Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.

Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York

Dr. Soin, Dr. Anbarasan, and Dr. Aiken have no financial relationships with companies related to this material.

As antipsychotic indications have spread, more patients are taking them in combination with their opposite: a stimulant. We look at the risks, search for scenarios where it might make sense, and come up with an action plan for this paradoxical pairing.